Five-Year Outcomes of a Phase 1/2 Trial of Accelerated Partial Breast Irradiation Using Proton Therapy for Women With Stage 0-IIA Breast Cancer

Overview

Journal Adv Radiat Oncol

Specialty Oncology

Date 2024 Feb 26

PMID 38405317

Authors

Gary M Freedman

Taoran Li

Elizabeth Garver

Katherine Shillington

Bridget Shinkle

Julia C Tchou

Oluwadamilola M Fayanju

Lilie Lin

Neil K Taunk

Affiliations

Soon will be listed here.

Abstract

Purpose: We report the results of a phase 1/2 trial of external beam partial breast radiation using proton therapy.

Methods And Materials: Eligible patients included stage 0-IIA breast cancer pTis-T2, N0, and size ≤3 cm. Proton beam radiation was used to deliver 3.85 Gy twice daily to 38.5 Gy. The phase 1 portion determined feasibility based on criteria of successful plan creation, treatment delivery, and acute toxicity grade ≥3 in ≤20% of patients. The phase 2 portion had efficacy goals of acute toxicity grade ≥3 in ≤20% of patients and observing physician-rated cosmesis of excellent or good >85% of patients at 2 years.

Results: From April 2013 to March 2015, there were 12 patients enrolled onto the phase 1 portion, and the preplanned analysis of feasibility was met in all 4 required criteria. From July 2015 through December 2019 there were 28 patients with 29 treated breasts (1 bilateral) enrolled onto the phase 2 portion of the trial out of 45 originally planned. The trial was closed to accrual because of the coronavirus pandemic and not reopened. Thirty-eight breasts were treated with double-scattering and 3 pencil-beam scanning protons. The median follow-up of the 40 patients is 5.4 years (range, 2.3-8.6 years). There was 1 local recurrence. There was no grade ≥3 acute or late toxicity. At baseline all patients had physician-rated cosmesis good or excellent but at 2 years was excellent in 56%, good in 19%, and fair in 25%.

Conclusions: Proton-accelerated partial breast irradiation delivered with a twice-daily fractionation was feasible and associated with very low acute and long-term toxicity. However, the trial did not meet goals for cosmesis outcomes and was closed prematurely. Future study is needed to determine whether pencil-beam scanning protons or different fractionation could improve these outcomes.

References

Pasalic D, Strom E, Allen P, Williamson T, Poenisch F, Amos R . Proton Accelerated Partial Breast Irradiation: Clinical Outcomes at a Planned Interim Analysis of a Prospective Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2020; 109(2):441-448. DOI: 10.1016/j.ijrobp.2020.09.009. View

Hepel J, Tokita M, MacAusland S, Evans S, Hiatt J, Price L . Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2009; 75(5):1290-6. DOI: 10.1016/j.ijrobp.2009.01.009. View

Beadle G, Silver B, Botnick L, Hellman S, Harris J . Cosmetic results following primary radiation therapy for early breast cancer. Cancer. 1984; 54(12):2911-8. DOI: 10.1002/1097-0142(19841215)54:12<2911::aid-cncr2820541216>3.0.co;2-v. View

Wang X, Amos R, Zhang X, Taddei P, Woodward W, Hoffman K . External-beam accelerated partial breast irradiation using multiple proton beam configurations. Int J Radiat Oncol Biol Phys. 2010; 80(5):1464-72. PMC: 3249354. DOI: 10.1016/j.ijrobp.2010.04.052. View

Vicini F, Cecchini R, White J, Arthur D, Julian T, Rabinovitch R . Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet. 2019; 394(10215):2155-2164. PMC: 7199428. DOI: 10.1016/S0140-6736(19)32514-0. View

Berrang T, Olivotto I, Kim D, Nichol A, Cho B, Mohamed I . Three-year outcomes of a Canadian multicenter study of accelerated partial breast irradiation using conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2010; 81(5):1220-7. DOI: 10.1016/j.ijrobp.2010.07.2003. View

Bush D, Slater J, Garberoglio C, Do S, Lum S, Slater J . Partial breast irradiation delivered with proton beam: results of a phase II trial. Clin Breast Cancer. 2011; 11(4):241-5. DOI: 10.1016/j.clbc.2011.03.023. View

Stanton A, Krishnan L, Collins C . Form or function? Part 1. Subjective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy. Cancer. 2001; 91(12):2273-81. View

Meattini I, Marrazzo L, Saieva C, Desideri I, Scotti V, Simontacchi G . Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial. J Clin Oncol. 2020; 38(35):4175-4183. DOI: 10.1200/JCO.20.00650. View

10.

Vicini F, Winter K, Wong J, Pass H, Rabinovitch R, Chafe S . Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma. Int J Radiat Oncol Biol Phys. 2009; 77(4):1120-7. PMC: 3365530. DOI: 10.1016/j.ijrobp.2009.06.067. View

11.

Arthur D, Winter K, Kuske R, Bolton J, Rabinovitch R, White J . A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys. 2008; 72(2):467-73. PMC: 2604132. DOI: 10.1016/j.ijrobp.2007.12.056. View

12.

Moon S, Shin K, Kim T, Yoon M, Park S, Lee D . Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy. Radiother Oncol. 2008; 90(1):66-73. DOI: 10.1016/j.radonc.2008.09.027. View

13.

Vicini F, Beitsch P, Quiet C, Gittleman M, Zannis V, Fine R . Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010; 79(3):808-17. DOI: 10.1016/j.ijrobp.2009.11.043. View

14.

Whelan T, Julian J, Berrang T, Kim D, Germain I, Nichol A . External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Lancet. 2019; 394(10215):2165-2172. DOI: 10.1016/S0140-6736(19)32515-2. View

15.

Kozak K, Katz A, Adams J, Crowley E, Nyamwanda J, Feng J . Dosimetric comparison of proton and photon three-dimensional, conformal, external beam accelerated partial breast irradiation techniques. Int J Radiat Oncol Biol Phys. 2006; 65(5):1572-8. DOI: 10.1016/j.ijrobp.2006.04.025. View

16.

Smith B, Arthur D, Buchholz T, Haffty B, Hahn C, Hardenbergh P . Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009; 74(4):987-1001. DOI: 10.1016/j.ijrobp.2009.02.031. View

17.

Polgar C, Major T, Fodor J, Sulyok Z, Somogyi A, Lovey K . Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol. 2010; 94(3):274-9. DOI: 10.1016/j.radonc.2010.01.019. View

18.

Vicini F, Winter K, Straube W, Wong J, Pass H, Rabinovitch R . A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group.... Int J Radiat Oncol Biol Phys. 2005; 63(5):1531-7. DOI: 10.1016/j.ijrobp.2005.06.024. View

19.

Jagsi R, Ben-David M, Moran J, Marsh R, Griffith K, Hayman J . Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2009; 76(1):71-8. PMC: 4414125. DOI: 10.1016/j.ijrobp.2009.01.041. View